An interventional study of eHealth Survivorship Support Tool and Control in Head and Neck Cancer (H&N), sponsored by Royal College of Surgeons, Ireland. Active, not recruiting at 1 site in Ireland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-23.
Sponsored by Royal College of Surgeons, Ireland · Not applicable, Interventional, and Supportive care
This study evaluates the development, implementation and effectiveness of a nurse-led eHealth support tool designed to improve quality of life and survivorship outcomes among adults treated for head and neck cancer. The intervention integrates symptom monitoring, self-management education, and structured survivorship support into routine follow-up care. Outcomes will include patient-reported quality of life, symptom burden, and healthcare utilization.
Head and neck cancer (HNC) survivors experience significant long-term physical, functional, and psychosocial sequelae including dysphagia, speech impairment, fatigue, pain, and psychological distress. Traditional follow-up models rely on periodic clinic visits and may not adequately support self-management.
This study involves three phases:
Development of a co-designed eHealth support platform.
Implementation of the intervention within survivorship care pathways.
Evaluation of clinical effectiveness using patient-reported outcomes and healthcare utilization metrics.
The intervention integrates:
Symptom tracking Educational resources Self-management tools Structured nurse-guided follow-up
The primary hypothesis is that structured digital survivorship support will improve global quality of life compared to usual follow-up care.
2,347 studies on the registry are indexed under Head and Neck Neoplasms; 553 are open to participants now.
This study's enrollment of 30 is below the median of 47 across 1,753 interventional studies indexed under Head and Neck Neoplasms.
Browse Head and Neck Neoplasms studies →Royal College of Surgeons, Ireland is the lead sponsor of 93 studies on the registry; 44 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adults ≥18 years Diagnosed with head and neck cancer Completed primary treatment (surgery, radiotherapy, chemotherapy or combination) Within 12 months post-treatment Access to smartphone/tablet/internet Able to provide informed consent
Exclusion Criteria:
Recurrent or metastatic disease requiring active treatment Significant cognitive impairment Inability to use digital device Non-English speakers (if tool not multilingual)
Intervention Name: eHealth Survivorship Support Tool Description: A digital platform including: Symptom monitoring Educational modules Self-management guidance Nurse-supported remote follow-up
Other: eHealth Survivorship Support Tool
Participants receive standard survivorship follow-up as per institutional guidelines.
Other: Control
A digital platform including: Symptom monitoring Educational modules Self-management guidance Nurse-supported remote follow-up
Standard follow up
Quality of Life EORTC QLQ-C30 (Global Health Status scale)
Measurement Tool: EORTC QLQ-C30 (Global Health Status scale) Time Frame: Baseline, 3 months, 6 months
Time frame: Baseline, 3 months, 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Royal College of Surgeons, Ireland